Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre P Zavascki

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Expert Review of Anti-Infective Therapy|March 27, 2014
Polymyxins for the treatment of extensively-drug-resistant Gram-negative bacteria: from pharmacokinetics to bedsideAlexandre P Zavascki
Antimicrobial Agents and Chemotherapy|December 21, 2016
Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?Alexandre P Zavascki, Roger L Nation
Current Pharmaceutical Biotechnology|December 31, 2013
Current status of Pseudomonas aeruginosa vaccineLessandra Michelim, Gregory Saraiva Medeiros, Alexandre P Zavascki
Antimicrobial Agents and Chemotherapy|March 25, 2015
In vitro activity of polymyxin B plus imipenem, meropenem, or tigecycline against KPC-2-producing Enterobacteriaceae with high MICs for these antimicrobialsNatália Barth, Vanessa B Ribeiro, Alexandre P Zavascki
Expert Review of Anti-Infective Therapy|November 7, 2013
Combination therapy for carbapenem-resistant Gram-negative bacteriaAlexandre P Zavascki, Jurgen B Bulitta, Cornelia B Landersdorfer
Expert Review of Anti-Infective Therapy|April 5, 2017
Aminoglycosides against carbapenem-resistant Enterobacteriaceae in the critically ill: the pitfalls of aminoglycoside susceptibilityAlexandre P Zavascki, Brandon O Klee, Jürgen B Bulitta
Advances in Experimental Medicine and Biology|August 1, 2019
Clinical Use of Polymyxin BMaria Helena Rigatto, Diego R Falci, Alexandre P Zavascki
Mycopathologia|February 17, 2006
Fungal thyroiditis: an overviewLuciano Z Goldani, Alexandre P Zavascki, Ana Luiza Maia
Mycoses|October 20, 2007
Pneumocystis jiroveci thyroiditis: report of 15 cases in the literatureAlexandre P Zavascki, Ana L Maia, Luciano Z Goldani
The Journal of Antimicrobial Chemotherapy|August 6, 2010
The impact of polymyxin B dosage on in-hospital mortality of patients treated with this antibioticLaura S Elias, Daniele Konzen, Juliana M Krebs, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Expert Review of Anti-Infective Therapy|March 27, 2014
Polymyxins for the treatment of extensively-drug-resistant Gram-negative bacteria: from pharmacokinetics to bedsideAlexandre P Zavascki
Antimicrobial Agents and Chemotherapy|December 21, 2016
Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?Alexandre P Zavascki, Roger L Nation
Current Pharmaceutical Biotechnology|December 31, 2013
Current status of Pseudomonas aeruginosa vaccineLessandra Michelim, Gregory Saraiva Medeiros, Alexandre P Zavascki
Antimicrobial Agents and Chemotherapy|March 25, 2015
In vitro activity of polymyxin B plus imipenem, meropenem, or tigecycline against KPC-2-producing Enterobacteriaceae with high MICs for these antimicrobialsNatália Barth, Vanessa B Ribeiro, Alexandre P Zavascki
Expert Review of Anti-Infective Therapy|November 7, 2013
Combination therapy for carbapenem-resistant Gram-negative bacteriaAlexandre P Zavascki, Jurgen B Bulitta, Cornelia B Landersdorfer
Expert Review of Anti-Infective Therapy|April 5, 2017
Aminoglycosides against carbapenem-resistant Enterobacteriaceae in the critically ill: the pitfalls of aminoglycoside susceptibilityAlexandre P Zavascki, Brandon O Klee, Jürgen B Bulitta
Advances in Experimental Medicine and Biology|August 1, 2019
Clinical Use of Polymyxin BMaria Helena Rigatto, Diego R Falci, Alexandre P Zavascki
Mycopathologia|February 17, 2006
Fungal thyroiditis: an overviewLuciano Z Goldani, Alexandre P Zavascki, Ana Luiza Maia
Mycoses|October 20, 2007
Pneumocystis jiroveci thyroiditis: report of 15 cases in the literatureAlexandre P Zavascki, Ana L Maia, Luciano Z Goldani
The Journal of Antimicrobial Chemotherapy|August 6, 2010
The impact of polymyxin B dosage on in-hospital mortality of patients treated with this antibioticLaura S Elias, Daniele Konzen, Juliana M Krebs, et al.
Pageof 7